Paediatric Oncology & Haematology Group
The Paediatric Oncology & Haematology group has established itself as one of Europe’s strongest translational research teams with a specific focus both on leukaemia & lymphoma and on cancers in children.
The study of childhood cancer is a particular strength of the centre, which is home to one of the largest group of experts in this field in Europe.
As one of the strongest groups in paediatric and haematological cancer research in Europe, the Paediatric Oncology and Haematology Group aims to optimise current treatments and develop and advance novel therapies in patients with leukaemia or lymphoma and children with cancer.
Although there are similarities between paediatric and adult leukaemia and lymphoma, those in adulthood are often biologically different, can be associated with poor prognosis and represent a particular area of unmet clinical need.
Our vision
Optimise delivery and individualise therapy according to host and disease characteristics:
- Molecular classification of disease (prognostic and predictive biomarkers)
- Learn how chemotherapeutic approaches can be optimised through an improved knowledge of drug disposition and metabolism in paediatric patient populations
Develop novel treatments for patients with leukaemia/lymphoma and children with cancer:
- Identify novel targets, undertake pre-clinical drug development and advance promising new therapies to early clinical trials
Research areas:
- Leukaemia & Lymphoma
- Paediatric nervous system tumours
- Paediatric pharmacology and early phase clinical trials in children and young adults
Find out about our academic staff
